Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
125M
-
Shares change
-
+10.7M
-
Total reported value, excl. options
-
$5.75B
-
Value change
-
+$525M
-
Put/Call ratio
-
0.72
-
Number of buys
-
150
-
Number of sells
-
-84
-
Price
-
$45.93
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q3 2024
271 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q3 2024.
Avidity Biosciences, Inc. - Common Stock (RNA) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 125M shares
.
Largest 10 shareholders include FMR LLC (16.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.6M shares), BlackRock, Inc. (9.73M shares), VANGUARD GROUP INC (9.23M shares), RTW INVESTMENTS, LP (8.13M shares), WELLINGTON MANAGEMENT GROUP LLP (7.03M shares), Avoro Capital Advisors LLC (6.88M shares), RA CAPITAL MANAGEMENT, L.P. (6.3M shares), JANUS HENDERSON GROUP PLC (4.9M shares), and STATE STREET CORP (4.71M shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.